Pub. Date : 2017 Jul
PMID : 28483778
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Strong CYP2C8 inhibitors increased plasma exposure of dasabuvir (a major CYP2C8 substrate), OATP1B1/1B3 inhibitors increased plasma exposure of paritaprevir (an OATP1B1/1B3 substrate), and P-gp or BCRP inhibitors (all compounds are substrates of P-gp and/or BCRP) increased plasma exposure of the 3D regimen. | dasabuvir | cytochrome P450 family 2 subfamily C member 8 | Homo sapiens |
2 | Strong CYP2C8 inhibitors increased plasma exposure of dasabuvir (a major CYP2C8 substrate), OATP1B1/1B3 inhibitors increased plasma exposure of paritaprevir (an OATP1B1/1B3 substrate), and P-gp or BCRP inhibitors (all compounds are substrates of P-gp and/or BCRP) increased plasma exposure of the 3D regimen. | dasabuvir | cytochrome P450 family 2 subfamily C member 8 | Homo sapiens |